文献速递血管炎

独特的循环miRNA谱凸显白塞综合征的血栓炎症

A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome.
PubMed 文献 · Ann Rheum Dis · 2021-11-29

本研究通过微阵列筛查(16例白塞综合征患者和18例健康对照)及poly(T)接头PCR验证(30例患者和30例对照),发现miR-224-5p、miR-206和miR-653-5p在白塞综合征中失调,可区分患者与健康对照、活动性与非活动性疾病,以及白塞综合征与系统性红斑狼疮和巨细胞动脉炎;这些miRNA参与血栓炎症相关通路,并与白细胞活性氧产生和血浆脂质过氧化相关。

要点

  • 在白塞综合征患者中鉴定出29个差异表达的人循环miRNA。
  • 验证队列确认miR-224-5p、miR-206和miR-653-5p失调。
  • 这些miRNA与白细胞活性氧产生及血浆脂质过氧化显著相关。

核心结论

  • 本研究鉴定的循环miRNA谱可能代表一种新的、微创的白塞综合征生物标志物,并提示表观遗传调控参与白塞综合征相关的血栓炎症。

研究设计与样本

  • 研究采用微阵列在筛查队列(16例白塞综合征患者和18例健康对照)中评估血浆循环miRNA谱,随后在验证队列(30例白塞综合征患者和30例健康对照)中用poly(T)接头PCR(PTA-PCR)验证,并分析两个疾病对照组(30例系统性红斑狼疮患者和30例巨细胞动脉炎患者)。

主要发现

  • 微阵列筛查发现29个失调(差异表达)的人循环miRNA,层次聚类分析显示差异表达miRNA可将患者与对照清晰分开,且不依赖于临床特征。
  • 验证队列的PTA-PCR分析确认miR-224-5p、miR-206和miR-653-5p的失调。
  • 联合受试者工作特征(ROC)曲线分析显示这些循环miRNA可区分白塞综合征与健康对照(以及活动性与非活动性疾病),也可区分白塞综合征与系统性红斑狼疮及巨细胞动脉炎患者。
  • 功能注释分析(FAA)显示差异表达miRNA影响最富集的通路(即细胞-基质相互作用、氧化应激和血液凝固)与血栓炎症机制相关。
  • 验证队列中三种循环miRNA的表达与白细胞活性氧产生及血浆脂质过氧化显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Behçet's syndrome (BS) is a rare systemic vasculitis often complicated by thrombotic events. Given the lack of validated biomarkers, BS diagnosis relies on clinical criteria.In search of novel biomarkers for BS diagnosis, we determined the profile of plasmatic circulating microRNAs (ci-miRNAs) in patients with BS compared with healthy controls (HCs). METHODS: ci-miRNA profile was evaluated by microarray in a screening cohort (16 patients with BS and 18 HCs) and then validated by poly(T) adaptor PCR (PTA-PCR) in a validation cohort (30 patients with BS and 30 HCs). Two disease control groups (30 patients with systemic lupus erythematosus (SLE) and 30 patients with giant cell arteritis (GCA) were also analysed. RESULTS: From the microarray screening, 29 deregulated (differentially expressed (DE)) human ci-miRNAs emerged. A hierarchical cluster analysis indicated that DE ci-miRNAs clearly segregated patients from controls, independently of clinical features. PTA-PCR analysis on the validation cohort confirmed the deregulation of miR-224-5p, miR-206 and miR-653-5p. The combined receiver operating characteristic (ROC) curve analyses showed that such ci-miRNAs discriminate BS from HCs (and BS with active vs inactive disease), as well as BS from patients with SLE and GCA.The functional annotation analyses (FAAs) showed that the most enriched pathways affected by DE ci-miRNAs (ie, cell-matrix interaction, oxidative stress and blood coagulation) are related to thrombo-inflammatory mechanisms. Accordingly, the expression of the three ci-miRNAs from the validation cohort significantly correlated with leucocyte reactive oxygen species production and plasma lipid peroxidation. CONCLUSIONS: The ci-miRNA profile identified in this study may represent a novel, poorly invasive BS biomarker, while suggesting an epigenetic control of BS-related thrombo-inflammation.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Emmi G, Bagni G, Lastraioli E, et al. A unique circulating miRNA profile highlights thrombo-inflammation in Behçet's syndrome. Ann Rheum Dis. 2021. PMID: 34844932. doi:10.1136/annrheumdis-2021-220859

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。